DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Purchased by Pinebridge Investments L.P.

Pinebridge Investments L.P. lifted its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 42.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 90,843 shares of the medical instruments supplier’s stock after acquiring an additional 27,172 shares during the period. Pinebridge Investments L.P.’s holdings in DENTSPLY SIRONA were worth $1,724,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Riverview Trust Co acquired a new stake in DENTSPLY SIRONA in the 4th quarter valued at $26,000. MassMutual Private Wealth & Trust FSB raised its holdings in shares of DENTSPLY SIRONA by 648.4% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock valued at $27,000 after buying an additional 1,232 shares during the period. UMB Bank n.a. boosted its holdings in DENTSPLY SIRONA by 60.8% in the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier’s stock worth $28,000 after acquiring an additional 564 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. lifted its position in shares of DENTSPLY SIRONA by 700.0% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier’s stock worth $33,000 after purchasing an additional 1,568 shares in the last quarter. Finally, Signaturefd LLC boosted its stake in shares of DENTSPLY SIRONA by 513.3% in the fourth quarter. Signaturefd LLC now owns 4,428 shares of the medical instruments supplier’s stock valued at $84,000 after purchasing an additional 3,706 shares during the period. Hedge funds and other institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Stock Up 0.3 %

NASDAQ:XRAY opened at $13.75 on Monday. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. The stock has a 50 day moving average of $15.09 and a 200-day moving average of $18.25. The firm has a market capitalization of $2.74 billion, a PE ratio of -6.64, a price-to-earnings-growth ratio of 1.80 and a beta of 0.92. DENTSPLY SIRONA Inc. has a 52 week low of $12.16 and a 52 week high of $31.00.

DENTSPLY SIRONA Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 28th were given a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 4.65%. The ex-dividend date of this dividend was Friday, March 28th. DENTSPLY SIRONA’s dividend payout ratio is presently -14.07%.

Wall Street Analyst Weigh In

XRAY has been the subject of several recent analyst reports. Morgan Stanley downgraded DENTSPLY SIRONA from an “overweight” rating to an “equal weight” rating and set a $14.00 target price for the company. in a research note on Tuesday, April 15th. Barrington Research lowered their price objective on DENTSPLY SIRONA from $24.00 to $20.00 and set an “outperform” rating for the company in a research note on Friday, February 28th. Robert W. Baird cut their target price on DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating on the stock in a research report on Friday, February 28th. Jefferies Financial Group downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating and decreased their price target for the stock from $30.00 to $20.00 in a research report on Thursday, January 23rd. Finally, Evercore ISI reaffirmed an “in-line” rating and issued a $20.00 price target on shares of DENTSPLY SIRONA in a report on Tuesday, January 7th. Thirteen investment analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $22.58.

Insider Buying and Selling at DENTSPLY SIRONA

In other news, Director Gregory T. Lucier bought 15,142 shares of the firm’s stock in a transaction on Monday, March 3rd. The stock was purchased at an average price of $16.51 per share, for a total transaction of $249,994.42. Following the transaction, the director now owns 81,971 shares in the company, valued at approximately $1,353,341.21. This trade represents a 22.66 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through this link. 0.52% of the stock is currently owned by company insiders.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.